Immunization milestones: a more comprehensive picture of age-appropriate vaccination

Steve G Robison1, Samantha K Kurosky, Collette M Young

  • 1Immunization Program, State of Oregon Department of Human Services, 800 NE Oregon St., Suite 370, Portland, OR 97232, USA.

Insights

Childhood immunization coverage tracking needs improvement beyond current vaccine series up-to-date (UTD) rates. Milestone analysis reveals children often miss immunizations during provider visits, not just due to missed appointments.

Area of Science:

  • Public Health
  • Immunization Science
  • Health Informatics

Background:

  • Current childhood immunization coverage metrics, like vaccine series up-to-date (UTD) rates, offer limited insights for policy decisions.
  • Immunization registries require more informative measures to understand coverage gaps effectively.

Purpose of the Study:

  • To develop and apply a novel method combining milestone analysis with provider encounter data.
  • To identify specific reasons for incomplete childhood immunizations: missed provider visits versus missed vaccines during visits.

Main Methods:

  • Utilized milestone analysis to assess immunization status at critical ages between birth and two years.
  • Tracked immunization status of a large cohort of children using the Oregon ALERT immunization registry and Oregon Health Plan data.
  • Analyzed provider encounter data in conjunction with immunization records.

Main Results:

  • The majority of children exhibited fluctuating immunization status over time, moving between complete and incomplete coverage.
  • Standard UTD rates alone inaccurately attribute non-coverage primarily to missed provider visits.
  • Analysis revealed a significant proportion of children do not receive recommended immunizations even when visiting providers.

Conclusions:

  • Milestone analysis provides a more nuanced understanding of childhood immunization coverage dynamics.
  • Policy-relevant insights can be gained by differentiating between missed visits and missed immunizations during encounters.
  • Rethinking coverage metrics is crucial for improving public health interventions and vaccination strategies.

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Immunological Memory01:23

Immunological Memory

Immunological memory, a pivotal pillar of the adaptive immune system, is responsible for the body's ability to remember and respond more swiftly and effectively to previously encountered pathogens. This remarkable feature is what makes vaccines so effective in preventing diseases.
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature is...
Active versus Passive Immunity01:31

Active versus Passive Immunity

Immunity, along with the ability to limit pathogen growth to prevent significant body tissue damage, can be gained either by (1) actively developing an immune response within the individual after exposure to a pathogen or after getting vaccinated or (2) passively transferring immune components from an immune individual to one who is nonimmune. Both these forms of immunity can be found naturally and in medical practices.
Active Immunity
Active immunity refers to the resistance one develops...
Vaccine Production01:23

Vaccine Production

Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...